How to effectively treat patients when access to specialized diagnostics and modern therapies for rare cancers is still sometimes limited? These are the issues that will be discussed by experts at the EURACAN board meeting, which will take place on November 7 and 8 at the Maria Sklodowska-Curie National Institute of Oncology - National Research Institute (NIP-PIB) in Warsaw.
European Reference Networks (ERNs) is an initiative of the European Commission working precisely for the benefit of patients with rare diseases, involving experts, providers and patient representatives from all over Europe. ERN EURACAN is a European Reference Network dedicated specifically to rare solid tumors in adults. The network was established by the European Commission in 2017, and brings together 106 highly specialized cancer centers from 26 European countries, as well as patient representatives from the ePAG (European Pacent Advocacy Group).
The National C...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
